GR3005677T3 - - Google Patents

Info

Publication number
GR3005677T3
GR3005677T3 GR920402003T GR920402003T GR3005677T3 GR 3005677 T3 GR3005677 T3 GR 3005677T3 GR 920402003 T GR920402003 T GR 920402003T GR 920402003 T GR920402003 T GR 920402003T GR 3005677 T3 GR3005677 T3 GR 3005677T3
Authority
GR
Greece
Application number
GR920402003T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005677T3 publication Critical patent/GR3005677T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920402003T 1987-01-28 1992-09-10 GR3005677T3 (enEXAMPLES)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882087 1987-01-28
JP6535287 1987-03-18

Publications (1)

Publication Number Publication Date
GR3005677T3 true GR3005677T3 (enEXAMPLES) 1993-06-07

Family

ID=26355556

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402003T GR3005677T3 (enEXAMPLES) 1987-01-28 1992-09-10

Country Status (6)

Country Link
EP (1) EP0284180B1 (enEXAMPLES)
KR (1) KR930006192B1 (enEXAMPLES)
CA (1) CA1323364C (enEXAMPLES)
DE (1) DE3873797T2 (enEXAMPLES)
ES (1) ES2043798T3 (enEXAMPLES)
GR (1) GR3005677T3 (enEXAMPLES)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
EP0410652B1 (en) * 1989-07-27 1995-05-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69018903T2 (de) * 1989-08-09 1995-08-24 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
PT978284E (pt) * 1997-11-28 2008-10-07 Sucampo Ag Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina
US6506799B1 (en) 1999-04-01 2003-01-14 Esperion Therapeutics, Inc. Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins

Also Published As

Publication number Publication date
DE3873797D1 (de) 1992-09-24
ES2043798T3 (es) 1994-01-01
EP0284180A1 (en) 1988-09-28
CA1323364C (en) 1993-10-19
EP0284180B1 (en) 1992-08-19
KR880008985A (ko) 1988-09-13
DE3873797T2 (de) 1993-01-21
KR930006192B1 (ko) 1993-07-08

Similar Documents

Publication Publication Date Title
GR3003732T3 (enEXAMPLES)
DE3780820D1 (enEXAMPLES)
AU5724886A (enEXAMPLES)
AU7243387A (enEXAMPLES)
AU6081986A (enEXAMPLES)
AU6232686A (enEXAMPLES)
AU6234086A (enEXAMPLES)
AU6301290A (enEXAMPLES)
AU6668286A (enEXAMPLES)
AU6799487A (enEXAMPLES)
AU6818487A (enEXAMPLES)
BR1101155A (enEXAMPLES)
AU5753086A (enEXAMPLES)
AU7737187A (enEXAMPLES)
AU7799887A (enEXAMPLES)
AU7152287A (enEXAMPLES)
AU5926286A (enEXAMPLES)
BG44932A1 (enEXAMPLES)
BG44564A1 (enEXAMPLES)
BG44640A1 (enEXAMPLES)
BG44646A1 (enEXAMPLES)
BG44673A1 (enEXAMPLES)
BG44678A1 (enEXAMPLES)
BG44699A1 (enEXAMPLES)
BG44588A1 (enEXAMPLES)